Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 2.61
(-3.33%)
AUD 2.61
(-3.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 8.33 Million AUD | 7.91% |
| 2023 | 7.72 Million AUD | 1.78% |
| 2022 | 7.58 Million AUD | 224.81% |
| 2021 | 2.33 Million AUD | 144.26% |
| 2020 | 956.09 Thousand AUD | -15.87% |
| 2019 | 1.13 Million AUD | 32.59% |
| 2018 | 857.04 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 8.33 Million AUD | 62.99% |
| 2024 Q1 | 4.89 Million AUD | -35.48% |
| 2024 FY | 8.33 Million AUD | 7.91% |
| 2024 Q4 | 8.33 Million AUD | 0.0% |
| 2024 Q2 | 5.11 Million AUD | 4.45% |
| 2023 FY | 7.72 Million AUD | 1.78% |
| 2023 Q4 | 7.58 Million AUD | 0.58% |
| 2023 Q3 | 7.54 Million AUD | -4.67% |
| 2023 Q2 | 7.91 Million AUD | 1.3% |
| 2023 Q1 | 7.81 Million AUD | 2.97% |
| 2022 Q2 | 2.61 Million AUD | 2.08% |
| 2022 Q1 | 2.56 Million AUD | 9.78% |
| 2022 FY | 7.58 Million AUD | 224.81% |
| 2022 Q4 | 7.58 Million AUD | 1.06% |
| 2022 Q3 | 7.5 Million AUD | 186.81% |
| 2021 Q4 | 2.33 Million AUD | 3.76% |
| 2021 Q1 | 1.92 Million AUD | 101.53% |
| 2021 FY | 2.33 Million AUD | 144.26% |
| 2021 Q2 | 2.01 Million AUD | 4.68% |
| 2021 Q3 | 2.25 Million AUD | 11.58% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 FY | 956.09 Thousand AUD | -15.87% |
| 2020 Q3 | 946.94 Thousand AUD | 0.0% |
| 2020 Q4 | 956.09 Thousand AUD | 0.97% |
| 2019 FY | 1.13 Million AUD | 32.59% |
| 2018 FY | 857.04 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -2615.263% |
| BTC Health Limited | 203.94 Thousand AUD | -3985.236% |
| CSL Limited | 27.88 Billion AUD | 99.97% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 70.362% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -696.822% |
| Orthocell Limited | 22.08 Million AUD | 62.27% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -412.432% |
| Race Oncology Limited | 1.91 Million AUD | -334.755% |
| Starpharma Holdings Limited | 8.69 Million AUD | 4.211% |
| AdAlta Limited | 3.54 Million AUD | -135.191% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 10.953% |
| Memphasys Limited | 5.59 Million AUD | -48.984% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -9623.932% |
| Acrux Limited | 5.68 Million AUD | -46.505% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -2161.324% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -123.247% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -611.474% |
| Nyrada Inc. | 855.63 Thousand AUD | -873.754% |
| PharmAust Limited | 896.6 Thousand AUD | -829.254% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 81.354% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -305.116% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -53.561% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -143.135% |
| Biome Australia Limited | 5.37 Million AUD | -55.06% |
| Biotron Limited | 737.5 Thousand AUD | -1029.718% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 34.924% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -97.008% |
| Immutep Limited | 10.97 Million AUD | 24.116% |
| Imugene Limited | 33.14 Million AUD | 74.861% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -1830.301% |
| Noxopharm Limited | 1.28 Million AUD | -546.567% |
| Patrys Limited | 691.36 Thousand AUD | -1105.117% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -258.268% |
| PYC Therapeutics Limited | 10.18 Million AUD | 18.188% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 96.659% |
| Dimerix Limited | 13.89 Million AUD | 40.029% |
| Hexima Limited | 248.67 Thousand AUD | -3250.528% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 80.516% |
| Nanollose Limited | 465.64 Thousand AUD | -1689.301% |
| Tissue Repair Ltd | 1.35 Million AUD | -516.754% |
| AnteoTech Limited | 4.07 Million AUD | -104.447% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -132.449% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 47.577% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -784.907% |
| Actinogen Medical Limited | 1.61 Million AUD | -415.781% |
| Immuron Limited | 2.84 Million AUD | -193.318% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -243.334% |